Expanding the use of the c-fos-tTA/TRE-ChR2 optogenetics model to similar tests would eliminate confounding factors such as anxiety and map responses of subpopulations to dietary polyphenols in alternate behavioral tests. The gene discussed is FOS; the disease is Anxiety.